Tryptophan depletion and attenuation of cue-induced craving for cocaine. 1995

S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA.

OBJECTIVE Although cocaine is a potent serotonin (5-HT) reuptake blocker, the role of 5-HT systems in cocaine craving and relapse in humans has been unclear. The authors evaluated whether acute reductions in central 5-HT synthesis modulated craving for cocaine in cocaine-dependent patients. METHODS Twenty-five cocaine-dependent male inpatients were exposed to cocaine-craving cues while their 5-HT levels were lowered and during a placebo condition in a counterbalanced, double-blind design. 5-HT levels were reduced by rapidly lowering plasma levels of its precursor, tryptophan; tryptophan levels were reduced by stimulating protein synthesis with a large drink of amino acids devoid of tryptophan. During the placebo condition the patients drank an identical amino acid drink containing tryptophan. Craving was induced by exposing patients to cocaine paraphernalia and a videotape depicting drug use. Craving was assessed 7 hours after ingestion of the drink. Visual analog ratings of craving for cocaine were administered before and after cue exposure at each test session. RESULTS Patients reported less desire for cocaine stimulated by cue exposure after drinking amino acids without tryptophan than they did after drinking placebo. The order that tryptophan depletion and placebo tests were performed influenced the impact of tryptophan depletion on cue-induced craving. CONCLUSIONS Serotonergic systems modulate cue-induced craving for cocaine, a factor implicated in relapse to cocaine use.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003463 Cues Signals for an action; that specific portion of a perceptual field or pattern of stimuli to which a subject has learned to respond. Cue
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D006185 Habituation, Psychophysiologic The disappearance of responsiveness to a repeated stimulation. It does not include drug habituation. Habituation (Psychophysiology),Habituation, Psychophysiological,Psychophysiologic Habituation,Psychophysiological Habituation,Habituations (Psychophysiology)
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations

Related Publications

S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
August 2001, Alcoholism, clinical and experimental research,
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
March 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
January 1999, The American journal of psychiatry,
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
July 2003, Clinical EEG (electroencephalography),
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
November 2000, The American journal of psychiatry,
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
January 1998, Drug and alcohol dependence,
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
February 1996, Lancet (London, England),
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
March 1999, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
October 2022, Translational psychiatry,
S L Satel, and J H Krystal, and P L Delgado, and T R Kosten, and D S Charney
February 2004, The American journal of psychiatry,
Copied contents to your clipboard!